Omeprazole

CHEMBL1503 Phase 4 承認済み Small molecule
Half-Life
0.5-1 hour
Bioavailability
Protein Binding
Molecular Weight
345.4 g/mol
LogP
2.2
Phase
4

Omeprazole is a proton pump inhibitor that shuts down stomach acid production at its source. It irreversibly blocks the H+/K+-ATPase, the enzyme that pumps acid into the stomach lumen, so a single dose can suppress secretion for far longer than its brief presence in the blood would suggest. This makes it effective for heartburn, acid reflux, and peptic ulcers. A small molecule (C17H19N3O3S) with a very short half-life of about half an hour to an hour, it nonetheless produces prolonged acid suppression because the enzyme must be newly synthesized before acid output recovers. Its action depends on activation within the acidic environment of the pump itself, targeting the tissue where it is needed. Omeprazole is an approved medicine widely used for acid-related digestive disorders.

A proton pump inhibitor blocking stomach acid production for heartburn, reflux, and ulcers.

分子量

345.4170 g/mol

LogP

2.20

TPSA

96.30 Ų

リピンスキーの五則

適合

治療領域

薬物分類

作用機序

Proton pump inhibitor that irreversibly blocks H+/K+-ATPase.

Pharmacokinetics (PK)

Half-Life 0.5-1 hour

Pharmacodynamics (PD)

機序

Proton pump inhibitor that irreversibly blocks H+/K+-ATPase.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1

InChI

InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)

Molecular Formula

C17H19N3O3S

HBD / HBA

1 / 6

回転可能結合数

5

重原子数

24

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A proton pump inhibitor blocking stomach acid production for heartburn, reflux, and ulcers.

Proton pump inhibitor that irreversibly blocks H+/K+-ATPase.

Key pharmacokinetic parameters for Omeprazole: Half-life: 0.5-1 hour.

Yes, Omeprazole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1503. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4594. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.